DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Cheap mega-capRe-rated
HALO
HALOZYME THERAPEUTICS INC
663 institutions still hold HALOZYME THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 40637H109·Biological Products, (No Diagnostic Substances)·663 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
663 institutions reported HALO in Q1 2026. BlackRock, Inc. leads at 20.9% of the visible book. +59 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 34
643 more holders available. Log in →